On Friday, William Blair initiated coverage on Tandem Diabetes Care Inc. TNDM and Beta Bionics Inc BBNX, noting that both ...

Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) in Q2 CY2026, with sales up 5.8% year on year to $254.6 million. The company’s outlook for the full year was close to analysts’ estimates ...

Tandem Diabetes shares jump 19.1% after a narrower-than-expected Q2 loss, as higher pump shipments and a 57% gross margin ...

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a ...

Investors in Tandem Diabetes Care Inc (Symbol: TNDM) saw new options begin trading today, for the July 29th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TNDM ...

About Tandem Diabetes Care Inc. Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its products include Tandem ...

Although the revenue and EPS for Tandem Diabetes Care (TNDM) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with ...

Tandem Diabetes Care TNDM remained under pressure on Monday, after the company accounted for plans of a combined analysis of three trials of its Control-IQ technology. Tandem Diabetes Care’s margins ...